44 research outputs found
Π‘ΡΠ°Π²Π½ΠΈΡΠ΅Π»ΡΠ½Π°Ρ ΠΎΡΠ΅Π½ΠΊΠ° ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² ΠΈΠ·ΠΌΠ΅ΡΠ΅Π½ΠΈΡ Π΅ΠΌΠΊΠΎΡΡΠΈ Π²Π΄ΠΎΡ Π° Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΏΠΎΠ±ΡΠ΄ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠ° ΠΈ ΠΌΠ΅ΡΠΎΠ΄Π° ΡΠ»ΡΡΡΠ°Π·Π²ΡΠΊΠΎΠ²ΠΎΠΉ ΡΠΏΠΈΡΠΎΠ³ΡΠ°ΡΠΈΠΈ Π² ΡΠ°Π½Π½Π΅ΠΌ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΌ ΠΏΠ΅ΡΠΈΠΎΠ΄Π΅ Ρ ΠΊΠ°ΡΠ΄ΠΈΠΎΡ ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ²
Incentive spirometry is one of the most common methods used for respiratory rehabilitation in the early period after cardiac surgery. Inspiratory capacity values, obtained by a patient using spirometer, are not reliably trusted.Objectives. To compare volumetric parameters measured with incentive spirometer and results obtained with bedside ultrasound-based spirometer to assure the feasibility of the use of incentive spirometry to assess the inspiratory capacity and eο¬ectiveness of postoperative respiratory rehabilitation.Materials and methods. The study included 50 patients after elective cardiac surgery. Pulmonary rehabilitation involved the use of various respiratory therapy methods. Spirography was performed before and after each session. Both approaches were used simultaneously to obtain the spirometry maximum inspiratory capacity (SMIC) with a bedside ultrasonic spirography and maximum inspiratory capacity (MIC) index using an incentive spirometer. Patientβs discomfort and adverse events during the procedures were recorded.Results. The absolute values of the MIC measured before and after each session by the two methods were dissimilar, however, the average increment values (6) did not show statistically significant differences. The correlation analysis revealed a strong positive statistically significant relationship between 6 SMIC and 6 MIC (R = 0.74 before the session, R = 0.79 after the session, R = 0.77 across the whole data set, P < 0.01), also consistent with the BlandβAltman analysis, evidencing that more than 95% of all values fell within Β± 1.96 SD of the mean difference. The inspiratory spirometry method showed good diagnostic accuracy (sensitivity 87%, specificity 85%, area under the curve (AUC) 0.8 (95% CI: [0.76; 0.83]), P < 0.001). Refusals of procedure were more often documented with ultrasonic spirography.Conclusion. The increment in the inspiratory capacity index measured with incentive spirometer shows good agreement with ultrasonic spirography measurements. Therefore, incentive spirometry can be reliably used to assess the effectiveness of respiratory rehabilitation interventions in cardiac surgery patients during early postoperative period.ΠΠΎΠ±ΡΠ΄ΠΈΡΠ΅Π»ΡΠ½Π°Ρ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠΈΡ ΠΎΡΠ½ΠΎΡΠΈΡΡΡ ΠΊ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΡΠΌ ΠΌΠ΅ΡΠΎΠ΄Π°ΠΌ, ΠΏΡΠΈΠΌΠ΅Π½ΡΠ΅ΠΌΡΠΌ Π΄Π»Ρ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΠΎΠΉ ΡΠ΅Π°Π±ΠΈΠ»ΠΈΡΠ°ΡΠΈΠΈ Π² ΡΠ°Π½Π½ΠΈΠ΅ ΡΡΠΎΠΊΠΈ ΠΏΠΎΡΠ»Π΅ ΠΊΠ°ΡΠ΄ΠΈΠΎΡ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
Π²ΠΌΠ΅ΡΠ°ΡΠ΅Π»ΡΡΡΠ². ΠΡΠΎΡΠ΅Π΄ΡΡΠ° ΠΎΡΠ½ΠΎΠ²Π°Π½Π° Π½Π° ΡΠ°ΠΌΠΎΡΡΠΎΡΡΠ΅Π»ΡΠ½ΠΎΠΌ ΠΈΠ·ΠΌΠ΅ΡΠ΅Π½ΠΈΠΈ ΠΎΠ±ΡΠ΅ΠΌΠ° Π²Π΄ΠΎΡ
Π° ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΌ, ΠΎΠ΄Π½Π°ΠΊΠΎ ΠΎΡΡΠ°Π΅ΡΡΡ Π½Π΅ΡΡΠ½ΡΠΌ, Π½Π°ΡΠΊΠΎΠ»ΡΠΊΠΎ ΠΌΠΎΠΆΠ½ΠΎ Π΄ΠΎΠ²Π΅ΡΡΡΡ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌ ΡΡΠΈΡ
ΠΈΠ·ΠΌΠ΅ΡΠ΅Π½ΠΈΠΉ. Β Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ. Π‘ΡΠ°Π²Π½ΠΈΡΡ Π²ΠΎΠ»ΡΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ, ΠΈΠ·ΠΌΠ΅ΡΠ΅Π½Π½ΡΠ΅ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΏΠΎΠ±ΡΠ΄ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠ° Ρ Π΄Π°Π½Π½ΡΠΌΠΈ ΠΏΡΠΈΠΊΡΠΎΠ²Π°ΡΠ½ΠΎΠΉ ΡΠ»ΡΡΡΠ°Π·Π²ΡΠΊΠΎΠ²ΠΎΠΉ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠΈΠΈ ΠΈ ΠΎΡΠ΅Π½ΠΈΡΡ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΏΠΎΠ±ΡΠ΄ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠΈΠΈ Π΄Π»Ρ ΠΎΡΠ΅Π½ΠΊΠΈ Π΅ΠΌΠΊΠΎΡΡΠΈ Β Β Π²Π΄ΠΎΡ
Π° ΠΈ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΉ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΠΎΠΉ ΡΠ΅Π°Π±ΠΈΠ»ΠΈΡΠ°ΡΠΈΠΈ.ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ.Β Π ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π²ΠΎΡΠ»ΠΈ 50 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΏΠΎΡΠ»Π΅ ΠΏΠ»Π°Π½ΠΎΠ²ΡΡ
ΠΊΠ°ΡΠ΄ΠΈΠΎΡ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΉ. Π Π΅Π°Π±ΠΈΠ»ΠΈΡΠ°ΡΠΈΡ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΡΡ
ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ². ΠΠΎ ΠΈ ΠΏΠΎΡΠ»Π΅ ΠΊΠ°ΠΆΠ΄ΠΎΠ³ΠΎ ΡΠ΅Π°Π½ΡΠ° Π²ΡΠΏΠΎΠ»Π½ΡΠ»ΠΈ ΡΠΏΠΈΡΠΎΠ³ΡΠ°ΡΠΈΡ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΏΡΠΈΠΊΡΠΎΠ²Π°ΡΠ½ΠΎΠ³ΠΎ ΡΠ»ΡΡΡΠ°Π·Π²ΡΠΊΠΎΠ²ΠΎΠ³ΠΎ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠ°. ΠΡΠ΅Π½ΠΈΠ²Π°Π»ΠΈ ΠΌΠ°ΠΊΡΠΈΠΌΠ°Π»ΡΠ½ΡΡ Π΅ΠΌΠΊΠΎΡΡΡ Π²Π΄ΠΎΡ
Π° (Π‘ΠΠΠΠ΄), ΠΎΠ΄Π½ΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ»ΠΈ Β ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Ρ ΠΌΠ°ΠΊΡΠΈΠΌΠ°Π»ΡΠ½ΠΎΠΉ Π΅ΠΌΠΊΠΎΡΡΠΈ Π²Π΄ΠΎΡ
Π° (ΠΠΠΠ΄) Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΏΠΎΠ±ΡΠ΄ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠ°. Π Π΅Π³ΠΈΡΡΡΠΈΡΠΎΠ²Π°Π»ΠΈΒ Π½Π΅ΠΆΠ΅Π»Π°ΡΠ΅Π»ΡΠ½ΡΠ΅ ΡΠ²Π»Π΅Π½ΠΈΡ ΠΈ Π΄ΠΈΡΠΊΠΎΠΌΡΠΎΡΡ ΠΏΡΠΈ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΈ ΠΏΡΠΎΡΠ΅Π΄ΡΡ.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠ±ΡΠΎΠ»ΡΡΠ½ΡΠ΅ Π²Π΅Π»ΠΈΡΠΈΠ½Ρ ΠΌΠ°ΠΊΡΠΈΠΌΠ°Π»ΡΠ½ΠΎΠΉ Π΅ΠΌΠΊΠΎΡΡΠΈ Π²Π΄ΠΎΡ
Π°, ΠΈΠ·ΠΌΠ΅ΡΠ΅Π½Π½ΡΠ΅ Π΄ΠΎ ΠΈ ΠΏΠΎΡΠ»Π΅ ΠΊΠ°ΠΆΠ΄ΠΎΠ³ΠΎ ΡΠ΅Π°Π½ΡΠ° Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΡΡΠ°Π²Π½ΠΈΠ²Π°Π΅ΠΌΡΡ
ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ², ΠΎΡΠ»ΠΈΡΠ°ΡΡΡΡ, ΠΎΠ΄Π½Π°ΠΊΠΎ ΡΡΠ΅Π΄Π½ΠΈΠ΅ Π·Π½Π°ΡΠ΅Π½ΠΈΡ ΠΈΡ
ΠΏΡΠΈΡΠΎΡΡΠ° (Ξ) Π½Π΅ ΠΈΠΌΠ΅Π»ΠΈ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΡΡ
ΡΠ°Π·Π»ΠΈΡΠΈΠΉ. ΠΠΎ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌ ΠΊΠΎΡΡΠ΅Π»ΡΡΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° Π²ΡΡΠ²Π»Π΅Π½Π° ΡΠΈΠ»ΡΠ½Π°Ρ ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½Π°Ρ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½Π°Ρ Π²Π·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·Ρ ΠΌΠ΅ΠΆΠ΄Ρ Ξ Π‘ΠΠΠΠ΄ ΠΈ Ξ ΠΠΠΠ΄ (Π΄ΠΎ ΡΠ΅Π°Π½ΡΠ° r = 0,74, ΠΏΠΎΡΠ»Π΅ ΡΠ΅Π°Π½ΡΠ° r = 0,79, ΠΏΠΎ Π²ΡΠ΅ΠΌΡ ΠΌΠ°ΡΡΠΈΠ²Ρ Π΄Π°Π½Π½ΡΡ
r = 0,77, Β Ρ<0,01), ΠΊΠΎΡΠΎΡΠ°Ρ ΠΈΠΌΠ΅Π΅Ρ Ρ
ΠΎΡΠΎΡΡΡ ΡΠΎΠ³Π»Π°ΡΠΎΠ²Π°Π½Π½ΠΎΡΡΡ ΠΏΠΎ Π°Π½Π°Π»ΠΈΠ·Ρ ΠΠ»ΡΠ½Π΄Π°βΠΠ»ΡΡΠΌΠ°Π½Π°, ΠΎ ΡΠ΅ΠΌ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΠ΅Ρ ΡΠΎ, ΡΡΠΎ Β Π±ΠΎΠ»Π΅Π΅ 95% Π·Π½Π°ΡΠ΅Π½ΠΈΠΉΒ Π½Π°Ρ
ΠΎΠ΄ΠΈΠ»ΠΈΡΡ Π² ΠΏΡΠ΅Π΄Π΅Π»Π°Ρ
Β Β± 1,96 SD ΠΎΡ ΡΡΠ΅Π΄Π½Π΅ΠΉ ΡΠ°Π·Π½ΠΈΡΡ. ΠΠ΅ΡΠΎΠ΄ ΠΏΠΎΠ±ΡΠ΄ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠΈΠΈ ΠΏΠΎΠΊΠ°Π·Π°Π» Ρ
ΠΎΡΠΎΡΡΡ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΡΡ ΡΠΎΡΠ½ΠΎΡΡΡ ΠΏΡΠΈ ROC-Π°Π½Π°Π»ΠΈΠ·Π΅ (ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ 87%, ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ½ΠΎΡΡΡ 85%, ΠΏΠ»ΠΎΡΠ°Π΄Ρ ΠΏΠΎΠ΄ ΠΊΡΠΈΠ²ΠΎΠΉ (AUC) 0,8 (95% ΠΠ: [0,76;0,83]), Ρ<0,001). ΠΡΠΊΠ°Π· ΠΎΡ ΠΏΡΠΎΡΠ΅Π΄ΡΡΡ ΡΠ°ΡΠ΅ Π½Π°Π±Π»ΡΠ΄Π°Π»ΠΈ ΠΏΡΠΈ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠΈ ΠΌΠ΅ΡΠΎΠ΄Π° ΡΠ»ΡΡΡΠ°Π·Π²ΡΠΊΠΎΠ²ΠΎΠΉ ΡΠΏΠΈΡΠΎΠ³ΡΠ°ΡΠΈΠΈ.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΡΠΈΡΠΎΡΡ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Ρ Π΅ΠΌΠΊΠΎΡΡΠΈ Π²Π΄ΠΎΡ
Π°, ΠΈΠ·ΠΌΠ΅ΡΠ΅Π½Π½ΠΎΠΉ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΏΠΎΠ±ΡΠ΄ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠ°, Ρ
ΠΎΡΠΎΡΠΎ ΡΠΎΠ³Π»Π°ΡΡΠ΅ΡΡΡ Ρ ΠΈΠ·ΠΌΠ΅ΡΠ΅Π½Π½ΡΠΌ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΡΠ»ΡΡΡΠ°Π·Π²ΡΠΊΠΎΠ²ΠΎΠΉΒ ΡΠΏΠΈΡΠΎΠ³ΡΠ°ΡΠΈΠΈ ΠΈ ΠΌΠΎΠΆΠ΅Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°ΡΡΡΡ Π΄Π»Ρ ΠΎΡΠ΅Π½ΠΊΠΈ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΡΠ΅Π°Π±ΠΈΠ»ΠΈΡΠ°ΡΠΈΠΎΠ½Π½ΡΡ
ΠΌΠ΅ΡΠΎΠΏΡΠΈΡΡΠΈΠΉ Π² ΡΠ°Π½Π½Π΅ΠΌ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΌ ΠΏΠ΅ΡΠΈΠΎΠ΄Π΅ Ρ ΠΊΠ°ΡΠ΄ΠΈΠΎΡ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ²
Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists
It has now been demonstrated that the ΞΌ, Ξ΄(1), Ξ΄(2), and ΞΊ(1) opioid receptor (OR) agonists represent the most promising group of opioids for the creation of drugs enhancing cardiac tolerance to the detrimental effects of ischemia/reperfusion (I/R). Opioids are able to prevent necrosis and apoptosis of cardiomyocytes during I/R and improve cardiac contractility in the reperfusion period. The OR agonists exert an infarctβreducing effect with prophylactic administration and prevent reperfusionβinduced cardiomyocyte death when ischemic injury of heart has already occurred; that is, opioids can mimic preconditioning and postconditioning phenomena. Furthermore, opioids are also effective in preventing ischemiaβinduced arrhythmias
Activation of a glioma-specific immune response by oncolytic parvovirus Minute Virus of Mice infection
Rodent autonomous parvoviruses (PVs) are endowed with oncotropic properties and represent virotherapeutics with inherent oncolytic features. This work aimed to evaluate the capacity of Minute Virus of Mice (MVMp) to act as an adjuvant stimulating a mouse glioblastoma-specific immune response. MVMp was shown to induce cell death through apoptosis in glioma GL261 cells. Antigen-presenting cells (APCs) provide the initial cue for innate and adaptive immune responses, and thus MVMp-infected GL261 cells were tested for their ability to activate dendritic cells (DCs) and microglia (MG), two distinct cell types that are able to act as APCs. MG and discrete DC subsets were activated after co-culture with MVMp-infected glioma GL261 cells, as evidenced by upregulation of specific activation markers (CD80, CD86) and release of proinflammatory cytokines (tumor necrosis factor-a and interleukin-6). The in vivo analysis of immunodeficient and immunocompetent mice revealed a clear difference in their susceptibility to MVMp-mediated tumor suppression. Immunocompetent mice were fully protected from tumor outgrowth of GL261 cells infected ex vivo with MVMp. In contrast, immunodeficient animals were less competent for MVMp-dependent tumor inhibition, with only 20% of the recipients being protected, arguing for an additional immune component to allow full tumor suppression. In keeping with this conclusion, immunocompetent mice engrafted with MVMp-infected glioma cells developed a level of anti-tumor immunity with isolated splenocytes producing elevated levels of interferon-gamma. In rechallenge experiments using uninfected GL261 cells, we could show complete protection against the tumor, arguing for the induction of a T-cell-mediated, tumor-specific, long-term memory response. These findings indicate that the anticancer effect of PVs can be traced back not only for their direct oncolytic effect, but also to their ability to break tumor tolerance
Linear reduced cosserat medium with spherical tensor of inertia, where rotations are not observed in experiment
New materials for adsorption heat transformation and storage
Great current progress in the materials science offers an enormous choice of novel adsorbents which may be promising for transformation and storage of low temperature heat, e.g. from renewable heat sources. This paper gives an overview of recent trends and achievements in this field. We consider possible optimization of zeolites by dealumination, further development on aluminophosphates, composites salt in porous host matrice and metal-organic frameworks which are currently receiving the largest share of scientific attention. The particular attention is focused on the chemical nano-tailoring and tunable adsorption behavior of these materials to satisfy the demands of appropriate heat transformation cycles. We hope that this review will give new impact on target-oriented research on the novel adsorbents for heat transformation and storage
Improvement of Gemcitabine-Based Therapy of Pancreatic Carcinoma by Means of Oncolytic Parvovirus H-1PV
Human Retrotransposons and the Global Shutdown of Homeostatic Innate Immunity by Oncolytic Parvovirus H-1PV in Pancreatic Cancer
Although the oncolytic parvovirus H-1PV has entered clinical trials, predicting therapeutic success remains challenging. We investigated whether the antiviral state in tumor cells determines the parvoviral oncolytic efficacy. The interferon/interferon-stimulated genes (IFN/ISG)-circuit and its major configurator, human endogenous retroviruses (HERVs), were evaluated using qRT-PCR, ELISA, Western blot, and RNA-Seq techniques. In pancreatic cancer cell lines, H-1PV caused a late global shutdown of innate immunity, whereby the concomitant inhibition of HERVs and IFN/ISGs was co-regulatory rather than causative. The growth-inhibitory IC50 doses correlated with the power of suppression but not with absolute ISG levels. Moreover, H-1PV was not sensitive to exogenous IFN despite upregulated antiviral ISGs. Such resistance questioned the biological necessity of the oncotropic ISG-shutdown, which instead might represent a surrogate marker for personalized oncolytic efficacy. The disabled antiviral homeostasis may modify the activity of other viruses, as demonstrated by the reemergence of endogenous AluY-retrotransposons. This way of suppression may compromise the interferogenicity of drugs having gemcitabine-like mechanisms of action. This shortcoming in immunogenic cell death induction is however amendable by immune cells which release IFN in response to H-1PV
The cryopuncture method in treating patients with psoriatic arthritis
ΠΠ΅ΡΠΎΠ΄ ΠΊΡΠΈΠΎΠΏΡΠ½ΠΊΡΡΡΡ ΠΏΡΠ΅Π΄Π»ΠΎΠΆΠ΅Π½ Π΄Π»Ρ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΏΡΠΎΡΠΈΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠΌ Π°ΡΡΡΠΈΡΠΎΠΌ. ΠΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΊΡΠΈΠΎΠΏΡΠ½ΠΊΡΡΡΡ ΡΠΏΠΎΡΠΎΠ±ΡΡΠ²ΡΠ΅Ρ ΡΠ»ΡΡΡΠ΅Π½ΠΈΡ ΡΠ΅ΡΠ΅Π½ΠΈΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ ΠΈ ΡΠΌΠ΅Π½ΡΡΠ°Π΅Ρ Π±ΠΎΠ»Π΅Π²ΠΎΠΉ ΡΠΈΠ½Π΄ΡΠΎΠΌ. Method of cryopuncture therapy were proposed to treat patients with psoriatic arthritis. The use of cryotherapy contributes to improving the course of the disease, decreasing the pain syndrome